This inventor holds 2 USPTO granted patents. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Roland Vegner: Innovator in Intracellular Drug Delivery
Introduction
Roland Vegner is a notable inventor based in Riga, Latvia. He has made significant contributions to the field of drug delivery systems, particularly focusing on methods that enhance the transport of membrane-impermeable agents into cells. With a total of 2 patents to his name, Vegner's work is paving the way for advancements in medical therapies.
Latest Patents
Vegner's latest patents include innovative methods and compositions for facilitating the transport of membrane-impermeable extracellular agents with intracellular activity across cell membranes. His first patent describes the process of covalently coupling an amino terminal blocking group to a transport-mediating peptide, forming a carrier molecule. This carrier molecule is then covalently linked to the extracellular agent, resulting in a membrane-permeable prodrug. The transport-mediating peptides he developed are highly basic and specifically bind to polyphosphoinositides, enhancing their effectiveness in drug delivery.
Career Highlights
Roland Vegner is currently associated with The Brigham and Women's Hospital, Inc., where he continues to innovate in the field of drug delivery. His research focuses on improving the efficacy of treatments by ensuring that therapeutic agents can effectively penetrate cell membranes.
Collaborations
Vegner has collaborated with esteemed colleagues such as Paul A. Janmey and C. Casey Cunningham. These partnerships have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Roland Vegner's work in intracellular drug delivery represents a significant advancement in medical science. His innovative approaches and collaborations are likely to have a lasting impact on the field.